CHUGAI PHARMACEUTICAL CO., LTD- founded in 1925- is committed to providing high-quality healthcare and improving people's health, well-being and quality of life. With global horizon, Chugai is increasingly focusing on Research and Development (R＆D). Our mission today and tomorrow is to create exceptional added value in healthcare, and proceed to be a leading international health care company.
To service Taiwan, Chugai set up a Taipei branch company in 1988, and merged with HUEY MAW TRADING CO., LTD. to become CHUNG HUEY PHARMACEUTICAL CO., LTD. in 1991. In October 2001, the company officially changed the name to CHUGAI PHARMA TAIWAN and reran the business for marketing hospital-based products. Most of the pharmaceutical products import from Japan headquarters directly.
As of July 31st, 2015, Chugai Pharma Taiwan Ltd. and Chugai Pharma R&D Taiwan Ltd. merged with the aim to maximize the operational efficiency. Mission of new Chugai Pharma Taiwan is to add exceptional value through the activities of development, commercialization, and services for the benefit of the medical community and human health in Taiwan and extended to the world. We undertake actions that give the highest priority to patients and consumers.
We are dedicated to succeed as a pharmaceutical industry leader. Our mission as a member of the Chugai Group is to deliver exceptional value to stakeholders including patients, their families, and medical professionals through the creation of innovative medical products and services. We will continue to meet challenges in order to fulfill our mission, with all our activities firmly based on a strong ethical foundation as a company engaged in businesses related to the lives of human beings.
Major products
GRANOCYTE (Recombinant Human Granocyte Colony-Stimulating Factor Preparation)
SIGMART (Anti Angina Pectoris Agent)
